Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases
This work is licensed under the Creative Commons Attribution 4.0 International License.
Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, et al. The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer 2021; 157: 308–47. doi: 10.1016/j.ejca.2021.07.039DybaTRandiGBrayFMartosCGiustiFNicholsonNThe European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers20211573084710.1016/j.ejca.2021.07.039Open DOISearch in Google Scholar
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–49. doi: 10.3322/caac.21660SungHFerlayJSiegelRLLaversanneMSoerjomataramIJemalAGlobal cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries2021712094910.3322/caac.21660Open DOISearch in Google Scholar
Van Cutsem E, Nordlinger B, Adam R, Köhne CH, Pozzo C, Poston G, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006; 42: 2212–21. doi: 10.1016/j.ejca.2006.04.012Van CutsemENordlingerBAdamRKöhneCHPozzoCPostonGTowards a pan-European consensus on the treatment of patients with colorectal liver metastases20064222122110.1016/j.ejca.2006.04.012Open DOISearch in Google Scholar
Hackl C, Neumann P, Gerken M, Loss M, Klinkhammer-Schalke M, Schlitt HJ. Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer 2014; 14: 810. doi: 10.1186/1471-2407-14-810HacklCNeumannPGerkenMLossMKlinkhammer-SchalkeMSchlittHJTreatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma20141481010.1186/1471-2407-14-810Open DOISearch in Google Scholar
Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J. Colorectal cancer liver metastases – a population-based study on incidence, management and survival. BMC Cancer 2018; 18: 78. doi: 10.1186/s12885-017-3925-xEngstrandJNilssonHStrömbergCJonasEFreedmanJColorectal cancer liver metastases – a population-based study on incidence, management and survival2018187810.1186/s12885-017-3925-xOpen DOISearch in Google Scholar
Brecelj E, Velenik V, Reberšek M, Boc N, Oblak I, Zadnik V, et al. [Recommendations for the diagnosis and treatment of patients with colorectal cancer]. [Slovenian]. Onkologija 2020; 6: 60–92. doi: 10.25670/oi2020-012onBreceljEVelenikVReberšekMBocNOblakIZadnikV[Recommendations for the diagnosis and treatment of patients with colorectal cancer]. [Slovenian]20206609210.25670/oi2020-012onOpen DOISearch in Google Scholar
Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 016; 27: 1386–422. doi: 10.1093/annonc/mdw235Van CutsemECervantesAAdamRSobreroAVan KriekenJHAderkaDESMO consensus guidelines for the management of patients with metastatic colorectal cancer201627138642210.1093/annonc/mdw235Open DOISearch in Google Scholar
Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J, et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 2023; 34: 10–32. doi: 10.1016/j.annonc.2022.10.003CervantesAAdamRRosellóSArnoldDNormannoNTaïebJMetastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up202334103210.1016/j.annonc.2022.10.003Open DOISearch in Google Scholar
Fiorentini G, Sarti D, Nani R, Aliberti C, Fiorentini C, Guadagni S. Updates of colorectal cancer liver metastases therapy: review on DEBIRI. Hepatic Oncol 2020; 21;7: HEP16. doi: 10.2217/hep-2019-0010FiorentiniGSartiDNaniRAlibertiCFiorentiniCGuadagniSUpdates of colorectal cancer liver metastases therapy: review on DEBIRI2020217HEP1610.2217/hep-2019-0010Open DOISearch in Google Scholar
Scevola G, Loreni G, Rastelli M, Sposato S, Ramponi S, Miele V. Third-line treatment of colorectal liver metastases using DEBIRI chemoembolisation. Med Oncol 2017; 34: 37. doi: 10.1007/s12032-017-0890-9ScevolaGLoreniGRastelliMSposatoSRamponiSMieleVThird-line treatment of colorectal liver metastases using DEBIRI chemoembolisation2017343710.1007/s12032-017-0890-9Open DOISearch in Google Scholar
Szemitko M, Golubinska-Szemitko E, Sienko J, Falkowski A, Wiernicki I. Efficacy of liver chemoembolization after prior cetuximab monotherapy in patients with metastatic colorectal cancer. Cancers 2023; 15: 541. doi: 10.3390/cancers15020541SzemitkoMGolubinska-SzemitkoESienkoJFalkowskiAWiernickiIEfficacy of liver chemoembolization after prior cetuximab monotherapy in patients with metastatic colorectal cancer20231554110.3390/cancers15020541Open DOISearch in Google Scholar
Fereydooni A, Letzen B, Ghani MA, Miszczuk MA, Huber S, Chapiro J, et al. Irinotecan-eluting 75–150-mum embolics lobar chemoembolization in patients with colorectal cancer liver metastases: a prospective single-center Phase I study. J Vasc Interv Radiol 2018; 29: 1646–53. doi: 10.1016/j.jvir.2018.08.010FereydooniALetzenBGhaniMAMiszczukMAHuberSChapiroJIrinotecan-eluting 75–150-mum embolics lobar chemoembolization in patients with colorectal cancer liver metastases: a prospective single-center Phase I study20182916465310.1016/j.jvir.2018.08.010Open DOISearch in Google Scholar
Iezzi R, Marsico VA, Guerra A, Cerchiaro E, Cassano A, Basso M, et al. Transarterial chemoembolization with irinotecan-loaded drug-eluting beads (DEBIRI) and capecitabine in refractory liver prevalent colorectal metastases: a Phase II single-center study. Cardiovasc Intervent Radiol 2015; 6:1523–31. doi: 10.1007/s00270-015-1080-9IezziRMarsicoVAGuerraACerchiaroECassanoABassoMTransarterial chemoembolization with irinotecan-loaded drug-eluting beads (DEBIRI) and capecitabine in refractory liver prevalent colorectal metastases: a Phase II single-center study2015615233110.1007/s00270-015-1080-9Open DOISearch in Google Scholar
Martin RCG, Scoggins CR, Schreeder M, Rilling WS, Laing CJ, Tatum CM, et al. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis. Cancer 2015; 121: 3649–58. doi: 10.1002/cncr.29534MartinRCGScogginsCRSchreederMRillingWSLaingCJTatumCMRandomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis201512136495810.1002/cncr.29534Open DOISearch in Google Scholar
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the Cirse classification system. Cardiovasc Intervent Radiol 2017; 40: 1141–6. doi: 10.1007/s00270-017-1703-4FilippiadisDKBinkertCPellerinOHoffmannRTKrajinaAPereiraPLCirse quality assurance document and standards for classification of complications: the Cirse classification system2017401141610.1007/s00270-017-1703-4Open DOISearch in Google Scholar
Ocvirk J, Moltara ME, Mesti T, Boc M, Rebersek M, Volk N, et al. Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience. Radiol Oncol 2016; 50: 226–31. doi: 10.1515/raon-2015-0030OcvirkJMoltaraMEMestiTBocMRebersekMVolkNBevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience2016502263110.1515/raon-2015-0030Open DOISearch in Google Scholar
Saletti P, Molinari F, De Dosso S, Frattini M. EGFR signaling in colorectal cancer: a clinical perspective. Gastrointest Cancer Targets Ther 2015; 5: 21–38. doi: 10.2147/GICTT.S49002SalettiPMolinariFDe DossoSFrattiniMEGFR signaling in colorectal cancer: a clinical perspective20155213810.2147/GICTT.S49002Open DOISearch in Google Scholar
Martin J, Petrillo A, Smyth EC, Shaida N, Khwaja S, Cheow H, et al. Colorectal liver metastases: current management and future perspectives. World J Clin Oncol 2020; 11: 761–808. doi: 10.5306/wjco.v11.i10.761MartinJPetrilloASmythECShaidaNKhwajaSCheowHColorectal liver metastases: current management and future perspectives20201176180810.5306/wjco.v11.i10.761Open DOISearch in Google Scholar
Di Noia V, Basso M, Marsico V, Cerchiaro E, Rossi S, D’Argento E, et al. DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer. Future Oncol Lond Engl 2019; 15: 2349–60. doi: 10.2217/fon-2017-0025Di NoiaVBassoMMarsicoVCerchiaroERossiSD’ArgentoEDEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer20191523496010.2217/fon-2017-0025Open DOISearch in Google Scholar
Voizard N, Ni T, Kiss A, Pugash R, Raphael MJ, Coburn N, et al. Small particle DEBIRI TACE as salvage therapy in patients with liver dominant colorectal cancer metastasis: retrospective analysis of safety and outcomes. Curr Oncol Tor Ont 2022; 29: 209–20. doi: 10.3390/curroncol29010020VoizardNNiTKissAPugashRRaphaelMJCoburnNSmall particle DEBIRI TACE as salvage therapy in patients with liver dominant colorectal cancer metastasis: retrospective analysis of safety and outcomes2022292092010.3390/curroncol29010020Open DOISearch in Google Scholar
Pereira PL, Iezzi R, Manfredi R, Carchesio F, Bánsághi Z, Brountzos E, et al. The CIREL cohort: a prospective controlled registry studying the real-life use of irinotecan-loaded chemoembolisation in colorectal cancer liver metastases: interim analysis. Cardiovasc Intervent Radiol 2021; 44: 50–62. doi: 10.1007/s00270-020-02646-8PereiraPLIezziRManfrediRCarchesioFBánsághiZBrountzosEThe CIREL cohort: a prospective controlled registry studying the real-life use of irinotecan-loaded chemoembolisation in colorectal cancer liver metastases: interim analysis202144506210.1007/s00270-020-02646-8Open DOISearch in Google Scholar